A. Sanz Cantalapiedra-rekin lankidetzan egindako argitalpenak (6)

2009

  1. Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene

    Endocrine Journal, Vol. 56, Núm. 2, pp. 221-225

2008

  1. Bone mineral density, bone remodeling and osteoprotegerin in patients with acute coronary syndrome

    International Journal of Cardiology, Vol. 129, Núm. 1, pp. 144-145

  2. Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome

    European Review for Medical and Pharmacological Sciences, Vol. 12, Núm. 2, pp. 83-88

  3. Effect of the TNFα-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome

    Annals of Nutrition and Metabolism, Vol. 53, Núm. 2, pp. 117-121

2006

  1. Effects of statins on bone markers bone mineral density and fractures. Possible role in osteoporosis treatment

    Current Pharmaceutical Analysis, Vol. 2, Núm. 2, pp. 161-168

2005

  1. Effect of atorvastatin to RANKL/OPG system in patients with acute coronary syndrome

    Journal of Applied Research, Vol. 5, Núm. 4, pp. 569-574